A. Wunder
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Optical Imaging and Spectroscopy Techniques
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 4
- Oncology 7
- Cancer Treatment and Pharmacology 3
- Cancer survivorship and care 3
- Co-authors
- H. Sinn (10 shared papers)Ulrich Dirnagl (2 shared papers)Jan Klohs (2 shared papers)W. Maier‐Borst (6 shared papers)D. L. Heene (6 shared papers)G. Stehle (8 shared papers)H. H. Schrenk (5 shared papers)Steffen Gay (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)European Journal of Cancer (2 papers)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (1 paper)Lara D. Veeken (1 paper)Current Medicinal Chemistry (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
A. Wunder
22 papers receiving 399 citations
Peers
Comparison fields: 5 of 80
- Biomaterials 77
- Radiology, Nuclear Medicine and Imaging 118
- Neurology 30
- Hematology 30
- Biophysics 15
Countries citing papers authored by A. Wunder
This map shows the geographic impact of A. Wunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wunder more than expected).
Fields of papers citing papers by A. Wunder
This network shows the impact of papers produced by A. Wunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wunder. The network helps show where A. Wunder may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Wunder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society. | 1999 | 84 |
| 2 | 1997 | 63 | |
| 3 | 2008 | 55 | |
| 4 | 2000 | 43 | |
| 5 | 2008 | 39 | |
| 6 | 2005 | 39 | |
| 7 | 1992 | 22 | |
| 8 | 2005 | 17 | |
| 9 | 2003 | 15 | |
| 10 | 2005 | 8 | |
| 11 | 1995 | 6 | |
| 12 | 2012 | 6 | |
| 13 | 2023 | 4 | |
| 14 | Altered pharmacokinetic properties of a lipophilically derivatized low-molecular-weight heparin in rats. | 1993 | 4 |
| 15 | 2000 | 3 | |
| 16 | 2003 | 3 | |
| 17 | 1997 | 2 | |
| 18 | 2007 | 1 | |
| 19 | 2009 | 1 | |
| 20 | 1999 | 1 |
About A. Wunder
A. Wunder is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Biomedical Engineering and Public Health, Environmental and Occupational Health, having authored 23 papers that have together received 419 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), Cancer Treatment and Pharmacology (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Cancer survivorship and care (3 papers), Photoacoustic and Ultrasonic Imaging (2 papers) and Advanced Biosensing Techniques and Applications (2 papers). The work is most often cited by research in Biomaterials (77 citations), Radiology, Nuclear Medicine and Imaging (118 citations), Neurology (30 citations), Hematology (30 citations) and Biophysics (15 citations). A. Wunder has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include H. Sinn, Ulrich Dirnagl, Jan Klohs, W. Maier‐Borst, D. L. Heene, G. Stehle, H. H. Schrenk, Steffen Gay, Ulf Müller‐Ladner and E. Friedrich. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Lara D. Veeken and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.